Danny Hsu/LinkedIn
Oct 18, 2026, 06:26
Danny Hsu: BLOOD 2026 Return to Aotearoa
Danny Hsu, President of THANZ, Director of Therapeutic Apheresis, Immune and Obstetric Haematology at South Western Sydney Local Health District, shared a post on LinkedIn:
”BLOOD 2026 Return to Aotearoa!
Kicking off with the Thrombosis and Haemostasis Society of Australia and New Zealand Scientific Workshop!
Thank you to our Workshop Convenors, THANZ Vice President Charithani Keragala and Catherine Neal, for the great program!
A massive thank you to all our sponsors:
- Platinum – Sanofi (Australia)
- Gold – Sobi Australia
- Silver – Amgen Helena Laboratories (Australia) Stago CSL Roche Werfen Haematex Siemens Healthineers Alexion Pharmaceuticals,
- Inc. Novartis, Australia and New Zealand Novo Nordisk
Thank you to all our speakers, especially the legend Emmanuel J Favaloro for lugging the Seminars in Thrombosis and Hemostasis and massive textbooks as the door prize!”
See more in the gallery.
Stay updated with Hemostasis Today.
-
Oct 18, 2026, 07:05Behnood Bikdeli: Vasculearn Network Highlights Expert Perspectives on PE Risk Stratification and Advanced Therapies
-
Oct 18, 2026, 06:27Gregory Makris: NEJM Study Supports Earlier Catheter-Directed Intervention in Intermediate-High–Risk PE
-
Oct 18, 2026, 02:43Priya Sriskandarajah: Diagnosis and Management of PV and JAK2-Unmutated Erythrocytosis
-
Oct 18, 2026, 02:41C. Michael Gibson: A Meta-Analysis of DOACs and DAPT After Left Atrial Appendage Closure
-
Oct 18, 2026, 02:27What Hematologists Should Remember About the Person Behind the Platelet Count – ASH
-
Oct 18, 2026, 01:44Marta Velia Antonini: How to Deliver CRRT during ECMO?
-
Oct 18, 2026, 01:19Aamir Saeed: Anticoagulation, Cirrhosis, and Other Risk Factors for Post-ERCP Bleeding
-
Oct 18, 2026, 00:33Elad Asher: Does Opening the Clot Change How a Patient Feels Three Months Later?
-
Oct 18, 2026, 00:22Richa Sharma: Evaluating Heterogeneity in Anticoagulation Treatment Effects in Cryptogenic Stroke